Oncolytics Biotech Inc (ONCY) stock
ONCYNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.35−0.04 (-10.37%)
Close on Nov 20, 2026Market cap $44.64MP/E –Yield –
Oncolytics Biotech shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
Oncolytics Biotech's shares outstanding was 120M at Jun 30, 2026. For fiscal 2025 it was 96M, up 25.3% from the year before. Over ten years it grew 23.2% a year on average. The highest annual figure on record is 96M in fiscal 2025.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 96M | +25.3% |
| FY2024 | Dec 31, 2024 | 76M | +13.1% |
| FY2023 | Dec 31, 2023 | 68M | +16.5% |
| FY2022 | Dec 31, 2022 | 58M | +8.4% |
| FY2021 | Dec 31, 2021 | 54M | +32.7% |
| FY2020 | Dec 31, 2020 | 40M | +82.2% |
| FY2019 | Dec 31, 2019 | 22M | +38.2% |
| FY2018 | Dec 31, 2018 | 16M | +14.9% |
| FY2017 | Dec 31, 2017 | 14M | +10.4% |
| FY2016 | Dec 31, 2016 | 13M | +6.5% |
| FY2015 | Dec 31, 2015 | 12M | – |
Quarterly shares outstanding
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | 120M | – |
| Q1 FY2026 | Mar 31, 2026 | 112M | – |
| Q2 FY2025 | Jun 30, 2025 | 91M | – |
| Q1 FY2025 | Mar 31, 2025 | 85M | – |
See a number that looks wrong?